Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
about
Antibodies and antibody-derived analytical biosensorsRecent advances in micro/nanotechnologies for global control of hepatitis B infectionReal-time analysis of dual-display phage immobilization and autoantibody screening using quartz crystal microbalance with dissipation monitoringProteomic identification of novel differentiation plasma protein markers in hypobaric hypoxia-induced rat model.Single domain antibodies as a powerful tool for high quality surface plasmon resonance studies.A comparison of phosphospecific affinity reagents reveals the utility of recombinant Forkhead-associated domains in recognizing phosphothreonine-containing peptides.A High Through-put Platform for Recombinant Antibodies to Folded Proteins.Carbon nanotube biosensors.Antibody fragments as nanoparticle targeting ligands: a step in the right directionTargeted immunomodulation using antigen-conjugated nanoparticles.The Use of Antibodies in Small-Molecule Drug Discovery.Strategies in Ebola virus disease (EVD) diagnostics at the point of care.Carbon Nanomaterials in Biological Studies and Biomedicine.Current Status and Future Direction of Nanomedicine: Focus on Advanced Biological and Medical Applications.Antibody Engineering for Pursuing a Healthier FutureCarbon nanotubes: a novel material for multifaceted applications in human healthcare.Ligand-inducible dimeric antibody for selecting antibodies against a membrane protein based on mammalian cell proliferation.Construction of helper plasmid-mediated dual-display phage for autoantibody screening in serum.
P2860
Q28068441-A8AF7B8B-C989-4F3A-BF99-2759DB040A0FQ30394611-14D4B5E4-8841-4942-A66F-548CD8A5ABA1Q30404330-BED11D97-569C-45F4-888D-F81CAA351D60Q33632817-15765C73-6283-4EB7-9897-10D111A11975Q35590078-D803EA49-FBC7-4172-9F4B-7BB4C41187ECQ35895549-2BB2F815-DF33-453D-A44A-5EAF38A6B9C1Q36134059-8009413B-4FD6-4F51-A9F6-044CAC34BFBDQ36209397-4EBF8592-CD85-415B-A783-E1B315262E58Q36357291-71CE4EB4-E214-422C-8AE8-2078F152998AQ37705215-1A3A49AA-72C2-48B4-87F6-BBD8FAC9427DQ38201635-A492078D-6675-4473-B52D-340655765125Q38371191-86286AD2-203E-4ADB-97BE-C4CD713DBF03Q38646821-880FE2FA-1602-430B-89F0-362B43265B5DQ38676959-0A11E954-61EB-4125-B7AB-71D7E4AC9711Q38731632-1568015B-B056-4E8F-8F30-DD792938078AQ38795672-B2F91FD9-095C-4FE3-91F7-949EB4A44CB5Q38826849-C06BB012-8EF2-4485-9C9D-C042D6EF69DEQ41251697-9677C137-A2CA-428E-9C1F-3D4E14B1ADC6
P2860
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@ast
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@en
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@nl
type
label
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@ast
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@en
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@nl
prefLabel
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@ast
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@en
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@nl
P2860
P356
P1433
P1476
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
@en
P2093
Brian K Kay
Thomas D Cunningham
P2860
P356
10.3402/NANO.V3I0.17240
P577
2012-07-23T00:00:00Z